Digital Subscription

tool name

close
tool goes here

Amgen to pay $762 million to settle Aranesp case

Amgen will pay $762 million to settle litigation that accuses the drugmaker of marketing the anemia drug Aranesp for unapproved uses.

Published: Dec. 19, 2012 at 12:05 a.m. PST
0 comments

Amgen will pay $762 million to settle litigation that accuses the drugmaker of marketing the anemia drug Aranesp for unapproved uses.

A law firm involved in the case says the Thousand Oaks, Calif., company will pay a $612 million civil settlement, $136 million in criminal fines and a $14 million forfeiture.

Amgen Inc. says it entered a conditional guilty plea to a misdemeanor count of misbranding Aranesp. The company took a $780 million charge last year for a possible settlement.

Amgen develops biologic medicines, or drugs produced by living cells rather than by mixing chemicals. Its settlement marks the latest between the U.S. Department of Justice and a drugmaker over improper marketing allegations.

JOIN THE DISCUSSION | Register here

We welcome comments. Please keep them civil, short and to the point. ALL CAPS, spam, obscene, profane, abusive and off topic comments will be deleted. Repeat offenders will be blocked. Thanks for taking part — and abiding by these simple rules. A thorough explanation of rules of conduct can be found in our Terms of Service. If you have any questions, including why your comment may not be showing immediately after you submit it, be sure to visit the commenting FAQ.

SPORTS
SOUTH SOUND
BLOGS
CONTESTS

Similar stories

  • Amgen biotech purchasing genetics firm

    Biotech pioneer Amgen Inc., in a bid for a big edge in using people’s genetic information to find better ways to attack diseases, is buying human genetics research and analytics leader deCODE Genetics for $415 million.

  • Reynolds American sees 1st quarter income rise 88%

    Reynolds American Inc. said Tuesday that its first-quarter net income jumped 88 percent as higher prices and lower expenses from a longstanding legal settlement offset a decline in cigarette sales.

  • Insurer disputes Olympia Early Learning Center payouts

    The now-defunct Olympia Early Learning Center’s insurer is disputing the value of a $24.5 million settlement agreement for five civil lawsuits filed by families of a child who was raped and four pupils who were allegedly molested by former teaching assistant Eli Tabor.

  • Bujak, Canyon County may reach bankruptcy settlement

    After former Canyon County Prosecutor John Bujak filed his $1.3 million bankruptcy, the bankruptcy trustee sought to recover $171,000 Bujak had paid the county shortly before he resigned. Bankruptcy law allows trustees to seek return of any money the debtor paid in the three months previous to filing bankruptcy documents.

    The bankruptcy trustee sought not only the money Bujak paid the county, but other proceeds from the nearly $600,000 annual contract Bujak had to handle Nampa misdemeanor cases. County leaders countered that Bujak left office still owing the county about $300,000 from that contract.

    The two sides reached a proposed $20,000 settlement in March 2012, but a federal judge rejected that deal, saying it could be selling the bankruptcy estate short.

  • Citigroup to pay $730 million to settle class-action suit

    Citigroup has agreed to pay $730 million to settle a class-action lawsuit that claimed investors were misled by the bank’s disclosures when they purchased its debt and preferred stock.